19.02.2013 Views

Sample pages - Gale

Sample pages - Gale

Sample pages - Gale

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

04139 INTERVET COLOMBIA LTDA COLOMBIA<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 283,304,936 332,030,284<br />

Profit before tax 19,895,040 39,974,950<br />

Profit after tax 11,551,519 27,291,319<br />

Share capital 38,409,684 38,409,684<br />

Shareholders’ equity 160,815,558 175,383,976<br />

04139<br />

INTERVET COLOMBIA LTDA<br />

Address: Avenida Carrera 68 N0 17-64, Costado Occidental,<br />

Bogotá DC<br />

International tel: +57 (1) 417 5466<br />

International fax: +57 (1) 676 1080<br />

Website: www.intervet.com.co<br />

Company Registration Number: 830015923<br />

Management: Angelo Bolis Delair (Representante Legal),<br />

Steven Koehler (Gerente), Ricardo Rodriguez Chala (Contador),<br />

Michiel Stijn (Gerente)<br />

PRINCIPAL ACTIVITIES: Wholesale trade in animal healthcare<br />

products<br />

Parent Company: Merck & Co Inc., USA<br />

Status: Limited Liability Company<br />

Principal Shareholders: Merck & Co Inc., USA<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 26,164,750 41,509,987<br />

Profit before tax 1,626,129 5,345,163<br />

Profit after tax 943,607 3,505,693<br />

Share capital 777,550 777,550<br />

Shareholders’ equity 3,740,314 7,064,340<br />

04140<br />

JOHNSON & JOHNSON DE COLOMBIA S.A.<br />

J&J DE COLOMBIA SA<br />

Address: Apartado Postal 6530, Calle 15 No.31-146,<br />

Yumbo, Valle del Cauca<br />

International tel: +57 (2) 651 3333<br />

International fax: +57 (2) 651 3462<br />

Website: www.jnjcolombia.com.co<br />

Company Registration Number: 890101815<br />

Board of Directors: Martha Lucia Echeverry Piñeres (Director),<br />

Walter Grundy (Director), Adolfo Ignacio Ibarra Garcia<br />

(Director), Rosana Padilla Guevara (Representante Legal),<br />

Álvaro Palacio Restrepo (Gerente)<br />

Management: Luis Casallas Jimenez (Contador)<br />

PRINCIPAL ACTIVITIES: Manufacture of toiletries and pharmaceuticals<br />

Parent Company: Johnson & Johnson, USA<br />

Status: Non Quoted Public Company<br />

Principal Shareholders: Johnson & Johnson, USA<br />

Date of Establishment: 5 December 1962<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 618,617,523 661,504,288<br />

Profit before tax 67,776,661 68,557,686<br />

Profit after tax 42,723,961 46,464,929<br />

Share capital 1,852,846 1,852,846<br />

Shareholders’ equity 287,559,498 282,683,276<br />

04141<br />

LABORATORIOS BAXTER S.A.<br />

Address: Apartado Postal 2446, Calle 36 No.2C-22, Cali<br />

International tel: +57 (2) 444 7275; +57 (2) 444 7000<br />

International fax: +57 (2) 444 7412<br />

Website: www.latinoamerica.baxter.com/colombia<br />

Company Registration Number: 890300292<br />

Management: Mario Ciardelli Medina (Representante Legal),<br />

César Augusto González Ospina (Gerente), Carlos Alberto<br />

Roldan Aragon (Gerente), Hector Fauro Vargas Gutierrez<br />

(Contador)<br />

PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals<br />

Parent Company: Baxter International Inc, USA<br />

Status: Non Quoted Public Company<br />

Principal Shareholders: Baxter International Inc, USA<br />

536<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 525,103,917 547,374,636<br />

Profit before tax 122,665,101 159,258,131<br />

Profit after tax 83,187,057 107,577,164<br />

Share capital 1,000,926 1,000,926<br />

Shareholders’ equity 465,921,888 493,688,083<br />

04142<br />

MERCK S.A.<br />

Address: Calle 10 No. 65 28, Bogotá DC<br />

International tel: +57 (1) 425 4770<br />

International fax: +57 (1) 420 7819<br />

Company email: mcsa@merck.com.co<br />

Website: www.merck.com.co<br />

Company Registration Number: 860000580<br />

Board of Directors: Hernán Alfonso Briceño Rodríguez (Representante<br />

Legal), Carlos Arturo García Montoya (Director),<br />

Esteban Serrano Luciano (Director)<br />

Management: Luz Mery López Lagos (Gerente), Gladys Stella<br />

Lorenzana Huertas (Contador)<br />

PRINCIPAL ACTIVITIES: Manufacture of chemicals for use in<br />

the pharmaceutical and of pharmaceutical preparations<br />

Parent Company: Merck KGaA (02705)<br />

Status: Non Quoted Public Company<br />

Principal Shareholders: Merck KGaA, Germany<br />

Date of Establishment: 1957<br />

No of Employees: 523<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 320,061,690 278,006,162<br />

Profit before tax 73,916,856 37,215,672<br />

Profit after tax 50,079,535 24,879,572<br />

Share capital 14,356,030 14,356,030<br />

Shareholders’ equity 124,538,491 105,894,170<br />

04143<br />

NOVARTIS DE COLOMBIA S.A.<br />

NOVARTIS<br />

Address: Apartado Postal 123234, Calle 11 No.65-51,<br />

Bogotá DC<br />

International tel: +57 (1) 654 4444<br />

International fax: +57 (1) 446 4815<br />

Website: www.novartis.com<br />

Company Registration Number: 860002538<br />

Board of Directors: Maria Cristina Alvarez Rodriguez (Representante<br />

Legal), Jean Claude Dubos (Director), Carlos<br />

Dicken Garcia Iragorri (Director)<br />

Management: Carlos Leonardo Garcia Hewitt (Gerente),<br />

Evelyn Peña (Contador), Guillermo José Quintero Perdomo<br />

(Gerente)<br />

PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals<br />

aiming to prevent and cure diseases, to ease suffering and<br />

to enhance the quality of life<br />

Parent Company: Novartis AG (03653)<br />

Status: Non Quoted Public Company<br />

Principal Shareholders: Novartis AG, Switzerland (100%)<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 321,017,516 361,448,213<br />

Profit before tax 19,983,915 38,131,536<br />

Profit after tax 13,739,070 23,252,553<br />

Share capital 7,934,807 7,934,807<br />

Shareholders’ equity 113,709,095 100,584,514<br />

04144<br />

PFIZER S.A.<br />

PFIZER<br />

Address: Avenida El Dorado No.68B-85, Bogotá DC<br />

International tel: +57 (1) 417 8507<br />

International fax: +57 (1) 427 0070<br />

Website: www.pfizer.com.co<br />

Company Registration Number: 860039561<br />

Board of Directors: Luis Alberto Acuña González (Director),<br />

Luis Fernando Molano (Director), Francisco A Rodríguez<br />

Rodríguez (Director)<br />

Management: Juan Carlos Avila Bustos (Contador), Claudia<br />

Johanna Bohorquez Leon (Gerente), Andres Jordan Herrera<br />

(Representante Legal)<br />

PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals<br />

for human and veterinary use<br />

Parent Company: Pfizer Inc, USA<br />

Status: Non Quoted Public Company<br />

Principal Shareholders: Pfizer Inc, USA<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 280,354,399 472,014,510<br />

Profit before tax 32,416,267 21,092,880<br />

Profit after tax 18,947,634 13,203,872<br />

Share capital 30,332,357 30,332,357<br />

Shareholders’ equity 91,080,461 81,304,138<br />

04145<br />

PROCTER & GAMBLE COLOMBIA LTDA<br />

P & G Colombia Ltda<br />

Address: Apartado Postal 94611, Carrera 7 No.114-33, Piso<br />

12, Bogotá DC<br />

International tel: +57 (1) 520 8000<br />

International fax: +57 (1) 640 0013<br />

Website: www.pg.com<br />

Company Registration Number: 800000946<br />

Management: Carlos Alfredo Giraldo Aly (Representante Legal),<br />

Rafael Molina (Contador), Juan David Valencia Ocampo<br />

(Gerente), Víctor Karlo Velazquez Patron (Gerente)<br />

PRINCIPAL ACTIVITIES: Wholesale trade in personal care<br />

products, household cleaning items, laundry detergents,<br />

prescription drugs and disposable nappies<br />

Trade Names: Ariel, Pantele, Pert Plus, Camay, Crest<br />

Parent Company: Procter & Gamble Company, USA<br />

Status: Limited Liability Company<br />

Principal Shareholders: Procter & Gamble Company, USA<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 691,831,680 753,006,926<br />

Profit before tax 20,194,656 65,237,458<br />

Profit after tax 8,916,973 42,511,884<br />

Share capital 32,212,968 32,212,968<br />

Shareholders’ equity 194,600,815 200,152,052<br />

04146<br />

PRODUCTOS ROCHE S.A.<br />

Address: Carrera 44 No.17-21, Bogotá DC<br />

International tel: +57 (1) 417 8860<br />

International fax: +57 (1) 337 9270<br />

Website: www.roche.com.co<br />

Company Registration Number: 860003216<br />

Board of Directors: Hector Feliu (Director), Rolf Erik Honger<br />

(Representante Legal), Jorg Michael Rupp (Director)<br />

Management: Rodrigo Alonso Gómez Burbano (Gerente),<br />

Edith Marisol López Borbón (Contador)<br />

PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals<br />

Parent Company: Roche Holding AG (03668)<br />

Status: Non Quoted Public Company<br />

Principal Shareholders: Roche Holding AG, Switzerland<br />

(100%)<br />

Financial Information:<br />

31.12.09 31.12.10<br />

COP’000 COP’000<br />

Sales turnover 553,829,987 556,832,268<br />

Profit before tax 26,838,624 11,262,446<br />

Profit after tax 18,173,009 9,224,135<br />

Share capital 26,923,689 26,923,689<br />

Shareholders’ equity 202,200,282 218,813,820<br />

04147<br />

SANOFI-AVENTIS PHARMA S.A.<br />

SANOFI<br />

Address: Apartado Postal 6161, Transversal 23 N. 97-73,<br />

Piso 9, Bogotá DC<br />

International tel: +57 (1) 621 8400<br />

International fax: +57 (1) 621 4400<br />

Website: www.sanofi-aventis.com<br />

Company Registration Number: 830010337<br />

Board of Directors: Mauricio Botero Caicedo (Representante<br />

Legal), Stephen Edward Cobhan Scott (Director), Jesus<br />

Hernando Cubides Ballesteros (Director)<br />

Management: Giovanni Castillo Moreno (Contador), Hernando<br />

Suárez Ramírez (Gerente)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!